Scholars Central

Conference abstractPublished 8 Sep 2014

Quality by design- Regulatory considerations for pharmaceutical analytical methods

Authors: M V Narendra Kumar Talluri

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

QbD is a systematic process of building desirable quality in the end product by careful evaluation of all the attributes that go into characterizing quality, from the inception of a product to its end use, thus ensuring at any time that it meets patient needs. This initiative was introduced by the FDA in 2002 and is being promoted within the pharmaceutical industry with the aims of increasing regulatory flexibility and creating an easier path for the manufacturers to introduce process and product improvements. Recent pharmaceutical regulatory documents have stressed the critical importance of applying quality by design (QbD) principles for in-depth process understanding to ensure that product quality is built in by design. The concept of QbD can be extended to analytical methods. This article outlines the application of QbD concepts to the development of analytical methods, the methods are then carefully assessed in a structured manner for risks, and are challenged to determine the robustness and ruggedness criteria are satisfied. As a result of these studies, the method performance can be understood and improved if necessary and a control strategy can be defined to manage risk and ensure the method performs as desired when validated and deployed including high-performance liquid chromatography etc, for chemical identification, stability indicating methods and trace analysis for genotoxic impurities etc.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pharmaceutical Regulatory Affairs: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Regulatory Affairs: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “M V Narendra Kumar Talluri”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels